:: 5TH INTERNATIONAL WORKSHOP • FROM PATHOLOGY TO TREATMENT, WHATEVIDENCE IN INFLAMMATORY RHEUMATIC DISEASES? ARE THE HIGH-RISKINDIVIDUALS A NEW TREATM :: ECM
